(Q24201954)

English

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

scientific article

In more languages

Statements

scholarly article

0 references

0 references

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (English)

0 references

chronic inflammatory demyelinating polyradiculoneuropathy

0 references

0 references

Pieter A van Doorn

2

object named as

Pieter A van Doorn

0 references

author name string

Mohamed Mahdi-Rogers

1

0 references

Richard AC Hughes

3

0 references

publication date

14 June 2013

0 references

Cochrane Database of Systematic Reviews

0 references

Treatment for IgG and IgA paraproteinaemic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

129th ENMC International Workshop: Clinical Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy, 27th October 2004, Schiphol airport, The Netherlands.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

The AMC Linear Disability Score project in a population requiring residential care: psychometric properties

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

EBV-associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Distal acquired demyelinating symmetric neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Azathioprine toxicity in neuromuscular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Sustained remission of CIDP associated with Evans syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyneuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of inflammatory and paraproteinemic neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of dys-immune neuropathies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

"Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Subacute inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Nonmyeloablative autologous hematopoietic stem celltransplantation for refractory CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Clinical spectrum of chronic acquired demyelinating polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Chronic acquired demyelinating polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Mycophenolate in treatment-resistant inflammatory neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Interferon beta-1a as an investigational treatment for CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Treatment of Guillain-Barré syndrome and CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Systematic reviews of treatment for inflammatory demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Rituximab therapy in monoclonal IgM-related neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

21 January 2018

Subacute Idiopathic Demyelinating Polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic relapsing inflammatory demyelinating polyneuropathy by cyclosporin A and plasma exchange. A case report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic relapsing polyneuritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

[Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic polyneuropathies in Vest-Agder, Norway

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal upper limb demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab-responsive CIDP

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

CIDP cured by allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prevalence of CIDP and the association of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of monoclonal protein in peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifocal demyelinating neuropathy with persistent conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-beta1a in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide without stem-cell rescue for refractory CIDP

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferonbeta-1b therapy in a patient with childhood-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003280.PUB4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD003280.PUB4

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24201954&oldid=1475199760"